Developer docs
API playgroundTry for free, no card

Search company profiles

91Life

Full company profile

uuid0006ch8

Namestring
91Life
Legal namestring
91Life
Websiteurl
91.life
Company typeenum
Private
Founded yearint
2017
Descriptiontext

91Life is a privately held healthcare technology company founded in 2017 and headquartered in New York that builds Heart+, a cloud-native AI platform for remote and in-clinic monitoring of cardiac implantable electronic devices (CIEDs), ambulatory ECGs, and wearable cardiac data. The platform consolidates transmissions from the major device manufacturers (Abbott, Biotronik, Medtronic), uses machine learning to triage alerts, runs adaptive learning algorithms trained on physician feedback, and exposes a conversational AI assistant (Andra AI) for clinical Q&A and automated report generation. It maintains bidirectional, workflow-preserving integrations with the four dominant US acute-care EHR systems (Epic, Oracle Cerner, Athenahealth, MEDITECH) and operates HIPAA-compliant infrastructure.

The company sells primarily through a B2B enterprise field-sales motion targeting cardiology clinics and large health systems; named deployments include Yale New Haven Health System (multi-hospital, 5+ years), Mount Sinai (~3 years), and Valley Health. Strategic activity is anchored by the October 2024 acquisition of ScottCare Cardiovascular Solutions and a 2025 product enhancement focused on AI-driven reporting. The operating footprint spans New York, Prishtina (Kosovo), Tirana (Albania), and Marseille (France), and the leadership team comprises co-founders Bleron Baraliu (CEO) and Dr. Eleonora Gashi (CMO) alongside a bench of CTO, CFO/COO, CPO, and three VPs, with a PhD advisory board spanning digital twins, AI cardiology, and mathematical science. Documented customer outcomes at Yale include a reduction in patient enrollment errors from 60% to under 2%, a ~120% productivity increase, an 80% ROI improvement since 2021, and review-to-resolution time compressed from 24 hours to 6 hours during clinic hours.

The revenue model is subscription SaaS (Heart+ platform licensing) with custom enterprise contracts and embedded transaction components through auto-billing; a publicly listed pricing page referencing Starter/Premium/Business tiers ($28-$49/month) appears to be a template artifact inconsistent with the enterprise clinical model and should not be relied upon for valuation. No funding rounds, ARR, or revenue figures are disclosed, and ownership appears founder-controlled with no disclosed institutional investors in the available sources.

Short descriptiontext

91Life develops Heart+, a cloud-native AI platform for remote and in-clinic monitoring of cardiac implantable devices, ambulatory ECGs, and wearables, sold via enterprise SaaS to cardiology clinics and large health systems.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cardiac monitoring software, remote patient monitoring, cardiology AI platform, EHR-integrated diagnostics, implantable device monitoring
Industry4 codes
1AI/Analytics for RPM (Risk Stratification, Alerts, Predictive)
CodeHLACAFAMPrimaryYes
2Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
CodeHLALAFAAPrimaryNo
3Virtual Nursing, Telemonitoring & Command Center Platforms
CodeHLACAFAHPrimaryNo
4Remote Patient Monitoring (RPM) Platforms & Device Hubs (Connectivity/Gateways)
CodeHLAHACAHPrimaryNo
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Computer Programming Services7371
Product category
Cardiac Monitoring Software
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Subscription SaaS (Heart+ Platform)
TypeSubscription Recurring
Description

91Life generates revenue through subscription-based SaaS licensing of the Heart+ remote cardiac monitoring platform. The pricing appears to follow tiered plans (Starter, Premium, Business) with seat-based and potentially per-transmission or per-patient components. The platform includes auto-billing capabilities for clinical workflows, suggesting additional transaction-based revenue components.

91.life
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Starter - Free tier for up to 2 users
ModelFreemiumBilling cadenceMonthly
Notes

Free tier includes basic dashboard, 7 days version history, limited AI capabilities. Designed for small teams or evaluation.

91.life
2Premium - $28/month for up to 5 users
ModelSubscriptionBilling cadenceMonthly
Notes

Pro dashboard, 30 days version history, unlimited access to AI Basic. 3-day free trial available.

91.life
3Business - $49/month for teams and enterprise
ModelSubscriptionBilling cadenceMonthly
Notes

Business dashboard, unlimited version history, unlimited access to AI+ Pro. 7-day free trial available. Save 25% with annual billing.

91.life
4Enterprise - Custom pricing
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Advanced features and custom pricing available. Contact sales for exclusive offers. Includes dedicated engineer support and uptime SLA.

91.life
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Heart+
Description

AI-powered cloud-native platform for remote cardiac monitoring of implanted cardiac devices, ambulatory ECGs, and wearables with features including Smart Reviews, Andra AI conversational intelligence, and EHR integration.

91.life
Core offering1 text field

91Life develops and sells Heart+, a cloud-native AI-powered remote cardiac monitoring platform that consolidates data from cardiac-implantable electronic devices, ambulatory ECGs, and wearable devices. The platform uses machine learning for automated alert triage, clinical report generation, and auto-billing, and integrates bi-directionally with major EHR systems (Epic, Oracle Cerner, Athenahealth, MEDITECH) for cardiology clinics and health systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Reduced patient enrollment errors from 60% to under 2%
+4 more records
Product overview1 text field

91Life offers Heart+, a unified cloud-native AI-driven cardiac monitoring platform designed for remote patient monitoring of implanted cardiac devices and wearables. The platform includes Smart Reviews for AI-powered patient insights, Andra AI for conversational intelligence and automated report generation, and real-time device monitoring capabilities. Heart+ integrates with major EHR systems (Epic, Oracle Cerner, Athenahealth, MEDITECH) and provides HIPAA-compliant operations with adaptive learning algorithms enhanced by physician feedback.

Product and service1 record
1Heart+ Platform
CategoryCardiac Remote Monitoring Software
Description

Cloud-native AI-powered remote cardiac monitoring platform that automates in-clinic and remote monitoring of implanted cardiac devices for physicians and health systems. Consolidates data from CIEDs, ambulatory ECGs, and wearables; provides AI-driven alert triage, automated clinical workflows, and bi-directional EHR integration with Epic, Oracle Cerner, Athenahealth, and MEDITECH.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
1Abbott
Strategic tierCoreTypeTechnology or Integration
Description

Cardiac device manufacturer partnership enabling integration with Abbott implantable cardiac devices. Listed as partner logo on 91Life website, indicating device data connectivity within the Heart+ platform.

2Biotronik
Strategic tierCoreTypeTechnology or Integration
Description

Cardiac device manufacturer partnership enabling integration with Biotronik implantable cardiac devices. Listed as partner logo on 91Life website.

3Medtronic
Strategic tierCoreTypeTechnology or Integration
Description

Cardiac device manufacturer partnership enabling integration with Medtronic implantable cardiac devices. Listed as partner logo on 91Life website.

4Epic
Strategic tierCoreTypeTechnology or Integration
Description

EHR integration partnership with Epic for bi-directional data flow, real-time charting, and seamless EHR connectivity without workflow disruption.

5Oracle Cerner
Strategic tierCoreTypeTechnology or Integration
Description

EHR integration partnership with Oracle Cerner for bi-directional data flow and seamless charting integration.

91.life
6Athenahealth
Strategic tierCoreTypeTechnology or Integration
Description

EHR integration partnership with Athenahealth for seamless connectivity and data exchange.

7Yale New Haven Health System
Strategic tierFlagshipTypeImplementation/ SI/ Consulting Partner
Description

Flagship customer and implementation partner that implemented nurse-led digital health governance model with Heart+ platform across 5 hospitals for remote monitoring of cardiac implantable electronic devices. The partnership has generated documented outcomes including 120% productivity increase and 80% ROI improvement.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat6 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

91Life

Cardiac Monitoring Software91.life

91Life develops Heart+, a cloud-native AI platform for remote and in-clinic monitoring of cardiac implantable devices, ambulatory ECGs, and wearables, sold via enterprise SaaS to cardiology clinics and large health systems.

What 91Life does

91Life is a privately held healthcare technology company founded in 2017 and headquartered in New York that builds Heart+, a cloud-native AI platform for remote and in-clinic monitoring of cardiac implantable electronic devices (CIEDs), ambulatory ECGs, and wearable cardiac data. The platform consolidates transmissions from the major device manufacturers (Abbott, Biotronik, Medtronic), uses machine learning to triage alerts, runs adaptive learning algorithms trained on physician feedback, and exposes a conversational AI assistant (Andra AI) for clinical Q&A and automated report generation. It maintains bidirectional, workflow-preserving integrations with the four dominant US acute-care EHR systems (Epic, Oracle Cerner, Athenahealth, MEDITECH) and operates HIPAA-compliant infrastructure.

The company sells primarily through a B2B enterprise field-sales motion targeting cardiology clinics and large health systems; named deployments include Yale New Haven Health System (multi-hospital, 5+ years), Mount Sinai (~3 years), and Valley Health. Strategic activity is anchored by the October 2024 acquisition of ScottCare Cardiovascular Solutions and a 2025 product enhancement focused on AI-driven reporting. The operating footprint spans New York, Prishtina (Kosovo), Tirana (Albania), and Marseille (France), and the leadership team comprises co-founders Bleron Baraliu (CEO) and Dr. Eleonora Gashi (CMO) alongside a bench of CTO, CFO/COO, CPO, and three VPs, with a PhD advisory board spanning digital twins, AI cardiology, and mathematical science. Documented customer outcomes at Yale include a reduction in patient enrollment errors from 60% to under 2%, a ~120% productivity increase, an 80% ROI improvement since 2021, and review-to-resolution time compressed from 24 hours to 6 hours during clinic hours.

The revenue model is subscription SaaS (Heart+ platform licensing) with custom enterprise contracts and embedded transaction components through auto-billing; a publicly listed pricing page referencing Starter/Premium/Business tiers ($28-$49/month) appears to be a template artifact inconsistent with the enterprise clinical model and should not be relied upon for valuation. No funding rounds, ARR, or revenue figures are disclosed, and ownership appears founder-controlled with no disclosed institutional investors in the available sources.

91Life firmographics

Firmographics
Name
91Life
Legal name
91Life
Website
https://91.life
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
91Life develops Heart+, a cloud-native AI platform for remote and in-clinic monitoring of cardiac implantable devices, ambulatory ECGs, and wearables, sold via enterprise SaaS to cardiology clinics and large health systems.
Ownership category
akta.pro rank

91Life industry classification

Industry
Product category
Cardiac Monitoring Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Computer Programming Services (7371)
akta.pro primary industry
AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM)
akta.pro secondary industries
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Remote Patient Monitoring (RPM) Platforms & Device Hubs (Connectivity/Gateways) (HLAHACAH)

Keywords

  • Cardiac monitoring software
  • Remote patient monitoring
  • Cardiology AI platform
  • EHR-integrated diagnostics
  • Implantable device monitoring

Where 91Life is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices5 records

Markets served

91Life business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Subscription SaaS (Heart+ Platform): 91Life generates revenue through subscription-based SaaS licensing of the Heart+ remote cardiac monitoring platform. The pricing appears to follow tiered plans (Starter, Premium, Business) with seat-based and potentially per-transmission or per-patient components. The platform includes auto-billing capabilities for clinical workflows, suggesting additional transaction-based revenue components.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyStarter - Free tier for up to 2 users
SubscriptionMonthlyPremium - $28/month for up to 5 users
SubscriptionMonthlyBusiness - $49/month for teams and enterprise
SubscriptionMulti-year contractEnterprise - Custom pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

91Life product offering

Product offering

Core offering

91Life develops and sells Heart+, a cloud-native AI-powered remote cardiac monitoring platform that consolidates data from cardiac-implantable electronic devices, ambulatory ECGs, and wearable devices. The platform uses machine learning for automated alert triage, clinical report generation, and auto-billing, and integrates bi-directionally with major EHR systems (Epic, Oracle Cerner, Athenahealth, MEDITECH) for cardiology clinics and health systems.

Product overview

91Life offers Heart+, a unified cloud-native AI-driven cardiac monitoring platform designed for remote patient monitoring of implanted cardiac devices and wearables. The platform includes Smart Reviews for AI-powered patient insights, Andra AI for conversational intelligence and automated report generation, and real-time device monitoring capabilities. Heart+ integrates with major EHR systems (Epic, Oracle Cerner, Athenahealth, MEDITECH) and provides HIPAA-compliant operations with adaptive learning algorithms enhanced by physician feedback.

Differentiator

Problem solved

Functional benefit

Brands

  • Heart+: AI-powered cloud-native platform for remote cardiac monitoring of implanted cardiac devices, ambulatory ECGs, and wearables with features including Smart Reviews, Andra AI conversational intelligence, and EHR integration.

Products and services

  • Heart+ Platform Cloud-native AI-powered remote cardiac monitoring platform that automates in-clinic and remote monitoring of implanted cardiac devices for physicians and health systems. Consolidates data from CIEDs, ambulatory ECGs, and wearables; provides AI-driven alert triage, automated clinical workflows, and bi-directional EHR integration with Epic, Oracle Cerner, Athenahealth, and MEDITECH.

Quantifiable outcome

  • Reduced patient enrollment errors from 60% to under 2%
  • +4 more outcomes

Companies that use 91Life

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

91Life technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature8 records

91Life partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and flagship.

  • AbbottcoreTechnology or IntegrationCardiac device manufacturer partnership enabling integration with Abbott implantable cardiac devices. Listed as partner logo on 91Life website, indicating device data connectivity within the Heart+ platform.
  • BiotronikcoreTechnology or IntegrationCardiac device manufacturer partnership enabling integration with Biotronik implantable cardiac devices. Listed as partner logo on 91Life website.
  • MedtroniccoreTechnology or IntegrationCardiac device manufacturer partnership enabling integration with Medtronic implantable cardiac devices. Listed as partner logo on 91Life website.
  • EpiccoreTechnology or IntegrationEHR integration partnership with Epic for bi-directional data flow, real-time charting, and seamless EHR connectivity without workflow disruption.
  • Oracle CernercoreTechnology or IntegrationEHR integration partnership with Oracle Cerner for bi-directional data flow and seamless charting integration.
  • AthenahealthcoreTechnology or IntegrationEHR integration partnership with Athenahealth for seamless connectivity and data exchange.
  • Yale New Haven Health SystemflagshipImplementation/ SI/ Consulting PartnerFlagship customer and implementation partner that implemented nurse-led digital health governance model with Heart+ platform across 5 hospitals for remote monitoring of cardiac implantable electronic devices. The partnership has generated documented outcomes including 120% productivity increase and 80% ROI improvement.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

91Life competitors and assessment

Company assessment

Market position

Competitive moat6 records

Key highlights7 records

Customer concentration

91Life social profiles

Digital presence

91Life compliance and trust

Trust signal

Compliance1 record

91Life financial estimates

Financial estimate

Revenue estimate

Valuation estimate

91Life leadership team

Management profile

Number of profiles

Profiles12 records

91Life funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

91Life M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 91Life

What does 91Life do?

91Life develops and sells Heart+, a cloud-native AI-powered remote cardiac monitoring platform that consolidates data from cardiac-implantable electronic devices, ambulatory ECGs, and wearable devices. The platform uses machine learning for automated alert triage, clinical report generation, and auto-billing, and integrates bi-directionally with major EHR systems (Epic, Oracle Cerner, Athenahealth, MEDITECH) for cardiology clinics and health systems.

Is 91Life a public or private company?

91Life is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was 91Life founded?

91Life was founded in 2017. It employs 101 to 250 people.

Where is 91Life based?

91Life is headquartered in New York, United States, in the North America region.

How does 91Life make money?

One revenue line is on record: subscription SaaS (Heart+ Platform).

Does 91Life have an API?

Yes. Custom API integration tailored to your system is offered as part of the Heart+ platform. The platform supports custom API connectivity enabling integration with existing clinical systems.

What industry is 91Life in?

91Life's product category is Cardiac Monitoring Software. Its primary akta.pro industry code is HLACAFAM, AI/Analytics for RPM (Risk Stratification, Alerts, Predictive), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 54151 and its SIC code is 7371.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PulmonologyadvisorHow Can AI Improve Cardiac Care Within Health Systems? A Conversation With ExpertsThis interview-based article discusses how AI-based technologies, particularly 91Life's Heart+ remote cardiac monitoring platform, can improve cardiac care within health systems; Heart+ consolidates patient data from cardiac-implantable electronic devices, ambulatory ECGs, and wearable devices, then uses machine learning to triage alerts and auto-bill. The platform has been implemented at Mount Sinai for nearly 3 years and at Yale for over 5 years, with experts highlighting benefits such as improved clinician efficiency and patient outcomes while addressing concerns around data security, environmental impact, and potential biases. Expert sources from Northwestern Medicine and 91Life discuss the current landscape of AI in cardiovascular diagnostics, including ambient listening for clinical notes and AI algorithms embedded in imaging tools.The Cardiology AdvisorHow Can AI Improve Cardiac Care Within Health Systems? A Conversation With ExpertsThe article discusses the use of artificial intelligence (AI) in cardiac care, highlighting the Heart+ remote cardiac monitoring platform developed by 91Life, which has been implemented at Mount Sinai and Yale. It covers the current landscape, benefits, challenges, security measures, and future developments of AI in cardiology.EIN Presswire91Life Acquires Ambucor Services from Marmon Holdings, Inc., a Division of Berkshire Hathaway91Life has acquired Ambucor Services from Marmon Holdings, Inc., a division of Berkshire Hathaway, enhancing its offerings in remote cardiac monitoring solutions powered by AI and cloud technologies. This acquisition is expected to strengthen 91Life's position in the cardiac monitoring sector, enabling more effective solutions for clients. The move reflects a commitment to transforming healthcare through innovative, AI-driven tools and services.